2024-04-26 |
2024-04-24 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
1 000
-0.1%
14,06
100 000
USD
|
1 000
-0.1%
|
14,06
|
100 000
USD
|
|
2024-04-23 |
2024-04-23 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
1 000
-0.6%
14,29
100 000
USD
|
1 000
-0.6%
|
14,29
|
100 000
USD
|
|
2024-04-23 |
2024-04-22 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
1 000
-0.7%
14,05
100 000
USD
|
1 000
-0.7%
|
14,05
|
100 000
USD
|
|
2024-04-23 |
2024-04-19 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
1 000
-0.5%
14,02
100 000
USD
|
1 000
-0.5%
|
14,02
|
100 000
USD
|
|
2024-04-18 |
2024-04-18 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
2 623
-0.1%
14,06
36 879
USD
|
2 623
-0.1%
|
14,06
|
36 879
USD
|
|
2024-04-18 |
2024-04-17 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
300
-0.0%
14,15
4 245
USD
|
300
-0.0%
|
14,15
|
4 245
USD
|
|
2024-04-18 |
2024-04-16 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
14 069
-0.4%
14,01
197 107
USD
|
14 069
-0.4%
|
14,01
|
197 107
USD
|
|
2024-04-15 |
2024-04-12 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
23 101
-0.7%
14,42
333 116
USD
|
23 101
-0.7%
|
14,42
|
333 116
USD
|
|
2024-04-15 |
2024-04-11 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
461 899
-11.5%
14,49
6 692 917
USD
|
461 899
-11.5%
|
14,49
|
6 692 917
USD
|
|
2024-02-06 |
2024-02-05 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
3 446
-4.2%
15,17
52 278
USD
|
3 446
-4.2%
|
15,17
|
52 278
USD
|
|
2024-02-06 |
2024-02-02 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
14 143
-14.8%
15,07
213 122
USD
|
14 143
-14.8%
|
15,07
|
213 122
USD
|
|
2024-02-01 |
2024-02-01 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
663
-0.7%
15,04
9 971
USD
|
663
-0.7%
|
15,04
|
9 971
USD
|
|
2024-02-01 |
2024-01-31 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
1 923
-2.0%
15,08
28 990
USD
|
1 923
-2.0%
|
15,08
|
28 990
USD
|
|
2024-02-01 |
2024-01-30 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
11 262
-10.3%
15,10
170 004
USD
|
11 262
-10.3%
|
15,10
|
170 004
USD
|
|
2024-01-26 |
2024-01-25 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
1
-0.0%
15,00
15
USD
|
1
-0.0%
|
15,00
|
15
USD
|
|
2024-01-26 |
2024-01-24 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
827
-0.8%
15,03
12 426
USD
|
827
-0.8%
|
15,03
|
12 426
USD
|
|
2023-12-28 |
2023-12-27 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
13 300
-10.8%
10,12
134 648
USD
|
13 300
-10.8%
|
10,12
|
134 648
USD
|
|
2023-12-28 |
2023-12-26 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
102
-0.1%
10,00
1 020
USD
|
102
-0.1%
|
10,00
|
1 020
USD
|
|
2023-12-22 |
2023-12-20 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
2 730
-2.2%
10,14
27 695
USD
|
2 730
-2.2%
|
10,14
|
27 695
USD
|
|
2023-12-07 |
2023-12-06 |
VP
Vente planifiée
|
Morrell Martha
Chief Medical Officer
Dirigeant
|
11 005
-8.0%
8,16
89 773
USD
|
11 005
-8.0%
|
8,16
|
89 773
USD
|
|
2023-12-01 |
2023-12-01 |
V
Vente
|
KCK LTD.
Actionnaire important
|
3 241
-0.1%
8,73
28 294
USD
|
3 241
-0.1%
|
8,73
|
28 294
USD
|
|
2023-12-01 |
2023-11-30 |
V
Vente
|
KCK LTD.
Actionnaire important
|
7 282
-0.1%
8,84
64 373
USD
|
7 282
-0.1%
|
8,84
|
64 373
USD
|
|
2023-12-01 |
2023-11-29 |
V
Vente
|
KCK LTD.
Actionnaire important
|
5 644
-0.1%
8,72
49 216
USD
|
5 644
-0.1%
|
8,72
|
49 216
USD
|
|
2023-11-29 |
2023-11-28 |
V
Vente
|
KCK LTD.
Actionnaire important
|
4 681
-0.1%
8,75
40 959
USD
|
4 681
-0.1%
|
8,75
|
40 959
USD
|
|
2023-11-29 |
2023-11-27 |
V
Vente
|
KCK LTD.
Actionnaire important
|
6 490
-0.1%
8,96
58 150
USD
|
6 490
-0.1%
|
8,96
|
58 150
USD
|
|
2023-10-04 |
2023-10-03 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
700
-0.0%
9,02
6 314
USD
|
700
-0.0%
|
9,02
|
6 314
USD
|
|
2023-10-04 |
2023-10-02 |
V
Vente
|
ORBIMED ADVISORS LLC
Actionnaire important
|
7 614
-0.2%
9,08
69 135
USD
|
7 614
-0.2%
|
9,08
|
69 135
USD
|
|
2022-11-23 |
2022-11-22 |
A
Achat
|
Accelmed Partners II L.P.
Actionnaire important
|
62 398
+1.4%
1,50
93 535
USD
|
62 398
+1.4%
|
1,50
|
93 535
USD
|
|
2022-11-23 |
2022-11-21 |
A
Achat
|
Accelmed Partners II L.P.
Actionnaire important
|
327 893
+8.1%
1,50
491 512
USD
|
327 893
+8.1%
|
1,50
|
491 512
USD
|
|
2022-06-09 |
2022-06-08 |
VP
Vente planifiée
|
Ridley Irina
General Counsel and Secretary
Dirigeant
|
2 500
-3.9%
5,78
14 445
USD
|
2 500
-3.9%
|
5,78
|
14 445
USD
|
|
2022-03-01 |
2022-02-28 |
VP
Vente planifiée
|
Ridley Irina
General Counsel and Secretary
Dirigeant
|
1 470
-18.1%
7,54
11 082
USD
|
1 470
-18.1%
|
7,54
|
11 082
USD
|
|
2021-04-23 |
2021-04-21 |
A
Achat
|
Norton Evan
Administrateur non-exécutif
|
588 235
+inf%
17,00
9 999 995
USD
|
588 235
+inf%
|
17,00
|
9 999 995
USD
|
|
2021-04-23 |
2021-04-21 |
A
Achat
|
ORBIMED ADVISORS LLC
Actionnaire important
|
235 000
+inf%
17,00
3 995 000
USD
|
235 000
+inf%
|
17,00
|
3 995 000
USD
|
|
2021-04-23 |
2021-04-21 |
A
Achat
|
Accelmed Partners II L.P.
Actionnaire important
|
588 235
+inf%
17,00
9 999 995
USD
|
588 235
+inf%
|
17,00
|
9 999 995
USD
|
|
2021-04-23 |
2021-04-21 |
A
Achat
|
Fischer Frank M
Administrateur non-exécutif
|
50 000
+115.5%
17,00
850 000
USD
|
50 000
+115.5%
|
17,00
|
850 000
USD
|
|
2021-04-23 |
2021-04-21 |
A
Achat
|
Garfield Greg Shaw
Administrateur non-exécutif
|
13 235
+51.7%
17,00
224 995
USD
|
13 235
+51.7%
|
17,00
|
224 995
USD
|
|
2021-04-23 |
2021-04-21 |
A
Achat
|
Ridley Irina
General Counsel and Secretary
Dirigeant
|
2 352
+inf%
17,00
39 984
USD
|
2 352
+inf%
|
17,00
|
39 984
USD
|
|